Sara Ricardo

17PUBLICATIONS
57CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Proteomics and intermolecular interactions (excl. medical proteomics)Automated software engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 04, 2026
Re-Thinking Pharmacokinetics in Ovarian Cancer: What Do Organoids Add?

|Dec 30, 2025
Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines.

Nélia Fonseca, Mariana Nunes, Patrícia M A Silva

|May 04, 2025
P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma.

Rita Canário, Ana Sofia Ribeiro, Inês Morgado

|Jan 25, 2025
Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures.

Mariana Nunes, Sara Ricardo

|Nov 27, 2024
Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines.

Diana Luísa Almeida-Nunes, João P N Silva, Mariana Nunes

|May 10, 2024
Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options.

Mariana Nunes, Carla Bartosch, Miguel Henriques Abreu

Pageof 3

Frequent Collaborators

9 joint publications

Mariana Nunes

5 joint publications

Leonor David

2 joint publications

Marie Rubin Sander

2 joint publications

Johan Heldin